1
Return

Opportunities for Innovation in Smoking Cessation Therapies: A Perspective From the National Institutes of Health and US Food and Drug Administration

delete2025-01-01
delete0
PRE
AI
H
Haider J. Warraich *
B
Brian A. King
W
Wilson M. Compton
E
Evan S. Herrmann
M
Mary Thanh Hai
R
Robert M. Califf
M
Monica M. Bertagnolli
DOI:10.7326/ANNALS-24-02318delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En

Journal

Annals of Internal Medicine cover
Annals of Internal Medicine
IF:
15.2
Papers:
4.2W
Citations:
6.5W

Organization

N
national institutes of health (nih) - usa
Scholars:
10.2W
Papers: 8.2W
Citations: 111
U
us food & drug administration (fda)
Scholars:
1.4W
Papers: 9.3K
Citations: 3
Cited Papers

Cited Papers

Citing Papers

Citing Papers